- Home
- IPSC vs ICMB Comparison
IPSC vs ICMB Comparison
Compare IPSC & ICMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPSC
- ICMB
- Stock Information
- Founded
- IPSC 2019
- ICMB 2012
- Country
- IPSC United States
- ICMB United States
- Employees
- IPSC N/A
- ICMB N/A
- Industry
- IPSC Medicinal Chemicals and Botanical Products
- ICMB Finance: Consumer Services
- Sector
- IPSC Health Care
- ICMB Finance
- Exchange
- IPSC Nasdaq
- ICMB Nasdaq
- Market Cap
- IPSC 49.1M
- ICMB 42.1M
- IPO Year
- IPSC 2021
- ICMB N/A
- Fundamental
- Price
- IPSC $0.57
- ICMB $2.92
- Analyst Decision
- IPSC Strong Buy
- ICMB
- Analyst Count
- IPSC 5
- ICMB 0
- Target Price
- IPSC $3.33
- ICMB N/A
- AVG Volume (30 Days)
- IPSC 730.7K
- ICMB 38.9K
- Earning Date
- IPSC 11-04-2025
- ICMB 11-11-2025
- Dividend Yield
- IPSC N/A
- ICMB 16.89%
- EPS Growth
- IPSC N/A
- ICMB N/A
- EPS
- IPSC N/A
- ICMB 0.93
- Revenue
- IPSC $114,128,000.00
- ICMB $20,422,069.00
- Revenue This Year
- IPSC $1,589.94
- ICMB N/A
- Revenue Next Year
- IPSC N/A
- ICMB N/A
- P/E Ratio
- IPSC N/A
- ICMB $3.18
- Revenue Growth
- IPSC 5491.77
- ICMB N/A
- 52 Week Low
- IPSC $0.34
- ICMB $2.46
- 52 Week High
- IPSC $1.83
- ICMB $3.47
- Technical
- Relative Strength Index (RSI)
- IPSC 60.85
- ICMB 53.14
- Support Level
- IPSC $0.52
- ICMB $2.89
- Resistance Level
- IPSC $0.62
- ICMB $3.01
- Average True Range (ATR)
- IPSC 0.03
- ICMB 0.11
- MACD
- IPSC 0.01
- ICMB 0.01
- Stochastic Oscillator
- IPSC 64.94
- ICMB 71.00
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.